ArticleFrontiers in physiology2022

I-κB kinase-ε deficiency improves doxorubicin-induced dilated cardiomyopathy by inhibiting the NF-κB pathway.

Yafeng Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.